Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.
about
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia: implications for vaccine introductionSeroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, MexicoThe effects of vector movement and distribution in a mathematical model of dengue transmission.Economic and disease burden of dengue in Mexico.The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.Societal impact of dengue outbreaks: Stakeholder perceptions and related implications. A qualitative study in Brazil, 2015.Three-Month Real-Time Dengue Forecast Models: An Early Warning System for Outbreak Alerts and Policy Decision Support in Singapore.Introducing new vaccines in developing countries.Current issues in the economics of vaccination against dengue.Points for Consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.International Dengue Vaccine Communication and Advocacy: Challenges and Way Forward.Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.
P2860
Q28950695-1299BFBA-47C4-4DB4-9775-4646A431FB94Q34496118-9057CDF9-0E99-4A34-B93C-715B91CC666AQ35034544-79490240-AEC7-4D31-B8CC-BBF0DC1BD68BQ35192267-3332C086-2A34-4561-8B76-68A5F6362A94Q36206719-5AD20A8A-15D7-42C6-91F3-81F1BAA6A453Q36302212-93A997BF-1402-4B12-85A3-11A6B68E8618Q37230310-66D584F8-30A5-4CB7-A853-876041810B7CQ38160253-F818B7F4-B523-4019-84D2-9A08850054C2Q38661075-7B3182BC-1068-42BA-B612-C08FB3D4AAEDQ38664198-7D5A96BF-6FEB-459A-88B9-44176BCEC9F2Q38726041-01D575A7-3E06-4CE5-9CA7-2E42EE6600FCQ38966571-D857B378-496D-42C8-BCF7-3EE459CA7E29Q42977175-23D3BE66-B6F6-45DE-AC81-AF2B8E50CBCB
P2860
Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@ast
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@en
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@nl
type
label
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@ast
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@en
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@nl
prefLabel
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@ast
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@en
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@nl
P2093
P2860
P1476
Will dengue vaccines be used i ...... icymakers and opinion leaders.
@en
P2093
Denise A DeRoeck
Don L Douglas
Richard T Mahoney
P2860
P356
10.1371/JOURNAL.PNTD.0002127
P407
P50
P577
2013-03-14T00:00:00Z